OUR FOUNDER
Mark C. Siracusa, PhD
Mark is an Associate Professor in the Department of Medicine and the Center for Immunity and Inflammation at Rutgers New Jersey Medical School.
Mark received his PhD from Johns Hopkins University in Molecular, Microbiology and Immunology and did his Post doc at the University of Pennsylvania under David Artis.
Mark has published in multiple prestigious journals and has served as permanent member of the Innate Immunity and Inflammation NIH study section since 2022. Mark has been awarded multiple grants and currently holds 3 NIH R01s as a Principal Investigator.
Leadership
Martin Devenport, PhD, MBA
Chief Executive Officer
Martin brings over a decade of leadership experience in the biotechnology industry. Prior to this role, he served as Chief Operating Officer at GenrAb and OncoC4, where he oversaw key functions spanning research and development, GMP manufacturing, regulatory affairs, and clinical operations.
Research Team
Jianya Peng, PhD
John Ponessa, PhD
John Ponessa, PhD
Principle Scientist
10+ years of experience in studying host immune responses. Dr. Peng leads NemaGen's in-house drug development programs.
John Ponessa, PhD
John Ponessa, PhD
John Ponessa, PhD
Postdoctoral Scientist
Dr. Ponessa leads NemaGen's carbonic anhydrase pipeline drug development program.
Scientific and business advisory board
David Artis, PhD
Matthew Giannetti, MD
John Piwinski, PhD
Director, Jill Roberts Institute for Research in Inflammatory Bowel Disease and the Michael Kors Professor of Immunology, Department of Medicine at Weill Cornell
John Piwinski, PhD
Matthew Giannetti, MD
John Piwinski, PhD
Expertise in small molecule drug discovery with over 30 years of experience in medicinal chemistry
Matthew Giannetti, MD
Matthew Giannetti, MD
Adrian Piliponsky, PhD
Associate Director of the Brigham and Women's Hospital Mastocytosis Center. Dr. Giannetti treats patients with many mast cell disorders, including systemic mastocytosis.
Adrian Piliponsky, PhD
Adrian Piliponsky, PhD
Adrian Piliponsky, PhD
University of Washington Professor and Principal Investigator within the Center for Immunity and Immunotherapeutics at Seattle Children's Research Institute. Dr. Piliponsky is a renown mast cell biology expert.
Peter Grebow, PhD
Adrian Piliponsky, PhD
Peter Grebow, PhD
Former Senior Manager for many biotech companies, including Senior VP of Worldwide Business Development at Cephalon; VP, Drug Development for Rorer Central Research; and Executive VP of Research and Development at Eagle Pharmaceuticals.
Board of Directors
Mark Siracusa, PhD
Mark Siracusa, PhD
Mark Siracusa, PhD
President of NemaGen Discoveries
James Golubieski
Mark Siracusa, PhD
Mark Siracusa, PhD
President of Foundation Venture Capital Group